Clinic Consulting Management Manufacturing 
My Green Doctor
MAY 3, 2025
In This Issue : Why Renewable Energy Belongs in Every Clinic Medical Waste: One Model for Improvement OnTrack with your Sustainability Goals? Powering Health, Protecting the Planet – Why Renewable Energy Belongs in Every Clinic Healthcare professionals have always been trusted voices on public health.
My Green Doctor
MAY 3, 2025
Organizations such as EyeSustain and My Green Doctor are educating clinicians and practice managers on ways to reduce medical waste and are promoting research on this topic. Dilating and anesthetic eye drops are used routinely to treat patients in most ophthalmology clinics. tons in the United Kingdom each year. 3 “Each U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Imperial Center Family Medicine
JUNE 2, 2025
The liver manufactures new cholesterol molecules and captures excess from circulation for excretion. Multiple clinical studies verify that humans harboring elevated proportions of cholesterol-to-coprostanol converting bacteria tend to exhibit lower blood cholesterol levels and decreased risk for heart disease over time.
FDA Law
MARCH 3, 2024
Biotechnology services include advising or consulting services related to the use of the above equipment, disease detection, or genealogical information, or any other service for the research, development production, analysis, detection, or provision of information including data storage and transmission related to biological materials.
FDA Law
JANUARY 4, 2023
Brevig, Senior Regulatory Device and Biologics Expert — On December 7, 2022, FDA’s Center for Biologics Evaluation and Research (CBER) and the Office of Tissues and Advanced Therapies (OTAT) held a town hall to answer questions related to cell therapy and tissue-engineered products chemistry, manufacturing, and controls (CMC).
FDA Law
DECEMBER 16, 2024
The final guidance looks much like the prior draft and is intended to satisfy FDAs obligation to issue final guidance on consultations with persons under section 565(i) of the FD&C Act and also to provide clarity on use of third party emergency use authorization (EUA) review.
FDA Law
NOVEMBER 20, 2024
Chemical characterization can also be useful in evaluating a change to the materials or manufacturing of a device. FDA suggests that simulated use/leachables studies to simulate the clinical use (i.e., By Adrienne R. Many sponsors want to reduce animal testing and, therefore, welcome the approach.
Expert insights. Personalized for you.
52 
Let's personalize your content